Mizuho Medy Co.,Ltd. (4595.T)
JPY 1482.0
(-0.47%)
JPY 1482.0
(-0.47%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 3.27 Billion JPY | -32.1% |
| 2022 | 4.81 Billion JPY | 15.73% |
| 2021 | 4.16 Billion JPY | 83.6% |
| 2020 | 2.26 Billion JPY | -13.19% |
| 2019 | 2.61 Billion JPY | 7.65% |
| 2018 | 2.42 Billion JPY | 25.08% |
| 2017 | 1.94 Billion JPY | -9.55% |
| 2016 | 2.14 Billion JPY | 12.87% |
| 2015 | 1.9 Billion JPY | -7.63% |
| 2014 | 2.05 Billion JPY | 10.64% |
| 2013 | 1.86 Billion JPY | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 2.83 Billion JPY | -11.91% |
| 2024 Q1 | 3.21 Billion JPY | -1.73% |
| 2023 Q2 | 2.62 Billion JPY | -18.75% |
| 2023 Q3 | 2.99 Billion JPY | 14.16% |
| 2023 FY | 3.27 Billion JPY | -32.1% |
| 2023 Q4 | 3.27 Billion JPY | 9.25% |
| 2023 Q1 | 3.22 Billion JPY | -33.0% |
| 2022 Q3 | 3.9 Billion JPY | 18.86% |
| 2022 Q1 | 3.25 Billion JPY | -21.9% |
| 2022 FY | 4.81 Billion JPY | 15.73% |
| 2022 Q2 | 3.28 Billion JPY | 1.14% |
| 2022 Q4 | 4.81 Billion JPY | 23.26% |
| 2021 Q2 | 3.8 Billion JPY | 25.42% |
| 2021 Q4 | 4.16 Billion JPY | 7.73% |
| 2021 FY | 4.16 Billion JPY | 83.6% |
| 2021 Q1 | 3.03 Billion JPY | 33.64% |
| 2021 Q3 | 3.86 Billion JPY | 1.68% |
| 2020 Q1 | 2.18 Billion JPY | -16.42% |
| 2020 Q3 | 1.87 Billion JPY | -0.83% |
| 2020 FY | 2.26 Billion JPY | -13.19% |
| 2020 Q4 | 2.26 Billion JPY | 20.86% |
| 2020 Q2 | 1.89 Billion JPY | -13.35% |
| 2019 Q3 | 2.34 Billion JPY | 5.36% |
| 2019 FY | 2.61 Billion JPY | 7.65% |
| 2019 Q2 | 2.22 Billion JPY | 1.03% |
| 2019 Q1 | 2.19 Billion JPY | -9.43% |
| 2019 Q4 | 2.61 Billion JPY | 11.66% |
| 2018 Q4 | 2.42 Billion JPY | 40.25% |
| 2018 Q2 | 1.76 Billion JPY | -9.37% |
| 2018 Q3 | 1.73 Billion JPY | -1.95% |
| 2018 Q1 | 1.94 Billion JPY | 0.36% |
| 2018 FY | 2.42 Billion JPY | 25.08% |
| 2017 FY | 1.94 Billion JPY | -9.55% |
| 2017 Q2 | 1.52 Billion JPY | -11.74% |
| 2017 Q3 | 1.54 Billion JPY | 1.82% |
| 2017 Q4 | 1.94 Billion JPY | 25.24% |
| 2017 Q1 | 1.72 Billion JPY | -19.63% |
| 2016 Q1 | 1.84 Billion JPY | -3.03% |
| 2016 Q4 | 2.14 Billion JPY | 49.36% |
| 2016 Q3 | 1.43 Billion JPY | 2.32% |
| 2016 Q2 | 1.4 Billion JPY | -23.84% |
| 2016 FY | 2.14 Billion JPY | 12.87% |
| 2015 Q4 | 1.9 Billion JPY | 0.0% |
| 2015 FY | 1.9 Billion JPY | -7.63% |
| 2014 FY | 2.05 Billion JPY | 10.64% |
| 2013 FY | 1.86 Billion JPY | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Pharma Foods International Co., Ltd. | 24.98 Billion JPY | 86.904% |
| Takeda Pharmaceutical Company Limited | 7834.78 Billion JPY | 99.958% |
| Sumitomo Pharma Co., Ltd. | 751.37 Billion JPY | 99.564% |
| Shionogi & Co., Ltd. | 164.35 Billion JPY | 98.009% |
| Wakamoto Pharmaceutical Co.,Ltd. | 3.39 Billion JPY | 3.607% |
| Nippon Shinyaku Co., Ltd. | 42.86 Billion JPY | 92.366% |
| Kaken Pharmaceutical Co., Ltd. | 27.86 Billion JPY | 88.256% |
| Eisai Co., Ltd. | 494.82 Billion JPY | 99.339% |
| Morishita Jintan Co., Ltd. | 5.04 Billion JPY | 35.069% |
| Hisamitsu Pharmaceutical Co., Inc. | 61.69 Billion JPY | 94.696% |
| Mochida Pharmaceutical Co., Ltd. | 30.83 Billion JPY | 89.386% |
| Fuso Pharmaceutical Industries,Ltd. | 39.79 Billion JPY | 91.776% |
| Nippon Chemiphar Co., Ltd. | 31.08 Billion JPY | 89.472% |
| Tsumura & Co. | 132.88 Billion JPY | 97.537% |
| Kissei Pharmaceutical Co., Ltd. | 39.79 Billion JPY | 91.776% |
| Torii Pharmaceutical Co., Ltd. | 13.29 Billion JPY | 75.389% |
| Towa Pharmaceutical Co., Ltd. | 274.75 Billion JPY | 98.809% |
| Fuji Pharma Co., Ltd. | 44.15 Billion JPY | 92.589% |
| Zeria Pharmaceutical Co., Ltd. | 70.7 Billion JPY | 95.372% |
| KYORIN Holdings, Inc. | 46.89 Billion JPY | 93.021% |
| Taiko Pharmaceutical Co.,Ltd. | 7 Billion JPY | 53.27% |
| Daito Pharmaceutical Co.,Ltd. | 25.43 Billion JPY | 87.136% |
| SymBio Pharmaceuticals Limited | 8.14 Billion JPY | 59.807% |
| MedRx Co., Ltd | 129 Million JPY | -2436.849% |
| Solasia Pharma K.K. | 673 Million JPY | -386.261% |
| Modalis Therapeutics Corporation | 645.5 Million JPY | -406.974% |
| ASKA Pharmaceutical Holdings Co.,Ltd. | 31.38 Billion JPY | 89.572% |
| Sawai Group Holdings Co., Ltd. | 163.99 Billion JPY | 98.004% |
| Cyfuse Biomedical K.K. | 1.01 Billion JPY | -223.584% |
| Toho Holdings Co., Ltd. | 523.98 Billion JPY | 99.375% |
| Koa Shoji Holdings Co.,Ltd. | 6.95 Billion JPY | 52.929% |